Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT05729373

Public ClinicalTrials.gov record NCT05729373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Randomized, Double-blind, Parallel Group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in the Treatment of Adults With Generalized Anxiety Disorder

Study identification

NCT ID
NCT05729373
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
434 participants

Conditions and interventions

Interventions

  • SEP-363856 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2023
Primary completion
Sep 25, 2025
Completion
Sep 25, 2025
Last update posted
Oct 9, 2025

2023 – 2025

United States locations

U.S. sites
38
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
University of Alabama at Birmingham Huntsville Alabama 35801
IMA Clinical Research Phoenix Phoenix Arizona 85012
ProScience Research Group Culver City California 90230
Excell Research, Inc. Oceanside California 92056
Anderson Clinical Research Redlands California 92374
California Neuroscience Research, LLC Sherman California 91403
Schuster Medical Research Institute Sherman Oaks California 91403
Viking Pharmaceutical Trials Inc. dba Viking Clinical Research Temecula California 92591
CenExel Collaborative Neuroscience Research Torrance California 90502
Pacific Clinical Research Management Group Upland California 91786
CNS Healthcare Jacksonville Florida 32256
Combined Research Orlando Orlando Florida 32803
K2 Medical Research, LLC Tampa Florida 33607
CenExel iResearch Atlanta Atlanta Georgia 30030
Advanced Discovery Research LLC Atlanta Georgia 30318
NeuroTrials Research, Inc. Atlanta Georgia 30328
CenExel iResearch Savannah Savannah Georgia 31405
Uptown Research Institute, LLC Chicago Illinois 60640
American Medical Research, Inc. Warrenville Illinois 60555
Copley Clinical Boston Massachusetts 02116
Boston Clinical Trials Boston Massachusetts 02131
Adams Clinical Watertown Massachusetts 02472
Midwest Research Group Saint Charles Missouri 63304
Center for Emotional Fitness Site Cherry Hill New Jersey 08002
CenExel Hassman Research Institute Marlton New Jersey 08053
Social Psychiatry Research Institute Brooklyn New York 11235
Neurobehavioral Research, Inc. Cedarhurst New York 11516
Bioscience Research, LLC Mount Kisco New York 10016
Berman Clinical New York New York 10029
Manhattan Behavioral Medicine New York New York 10036
The Medical Research Network, L.L.C New York New York 10128
Neuro-Behavioral Clinical Research, Inc. North Canton Ohio 44720
Sooner Clinical Research Oklahoma City Oklahoma 73112
Paradigm Research Professionals, LLP Oklahoma City Oklahoma 73116
Lehigh Center for Clinical Research, LLC Allentown Pennsylvania 18104
Psychiatry and Psychotherapy Partners Austin Austin Texas 78737
FutureSearch Trials of Dallas, LP Dallas Texas 75231
Cedar Clinical Research, Inc. Draper Utah 84020

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05729373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05729373 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →